Effectiveness of a Structured Information interview in people with newly-diagnosed Multiple Sclerosis

Completed (inferred)MS (type not specified)ISRCTN81072971

What it found

Paper found, not read

A paper reports the results; we have not read it yet. See Papers below.

What it measured

Main measures

  • Primary endpoints, assessed one and six months after diagnosis disclosure, are knowledge and satisfaction with diagnosis communication as determined by the MS Knowledge Questionnaire (MSKQ) and the instrument "Comunicazione medico-paziente nella Sclerosi Multipla" (revised) (CoSM-R): 1. MSKQ: no widely-accepted measure of patient knowledge on MS is currently available. The MSKQ, specifically devis

    Quality of life (reported by participants)

Other measures (1)

  • Secondary endpoints are changes at one and six months in: 1. The Hospital Anxiety and Depression Scale (HADS) 2. The Control Preference Scale (CPS). The CPS was translated and cross-culturally adapted into Italian from the original English version. Other endpoints measured over the study period: 3. Attrition 4. Number of consultations 5. Number of visits to the MS centre

    Mood and sleep

Who could take part

MS (type not specified) · 18 and over

Show the full criteria

Inclusion criteria

Inclusion: Subjects are eligible for recruitment if all the following criteria are satisfied: 1. Diagnostic workup to confirm/exclude MS diagnosis 2. Age 18 years and above, either sex 3. Signed informed consent (pre-diagnostically) Consenting subjects will be randomised at the end of the diagnostic workup, provided that all the following criteria apply: 1. Diagnosis of MS confirmed 2. Interval between informed consent and MS diagnosis within seven months Exclusion: Subjects will be excluded from the study if one or more of the following criteria apply: 1. Previous MS diagnosis 2. Presence of definite cognitive compromise, psychiatric disease, or substance abuse

Exclusion criteria

Not separately supplied in the registry.

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

Not provided at time of registration

Papers

Loading reviews and guidelines…

History

    1. Started

      Mar 2008

    2. Finished

      Mar 2010

    Assembled by software from public sources.